Home » Business » Manufacturing
Shanghai center
By Richard Fu |
May 12, 2011, Thursday
|
Print Edition
Print Edition
Merck Millipore, the life science division of Germany's Merck, launched a US$2 million China biopharmaceutical technology center in Shanghai yesterday to provide support, training and validation services to drug-making customers.
"We are responding to China's commitment to strengthening regulatory requirements designed to ensure drug safety," said Jean-Paul Mangeolle, head of Merck Millipore's process solutions business.
Merck KGaA, which relies heavily on liquid crystals, the key chemical for TV screens, and on multiple sclerosis and cancer drugs for earnings, acquired American biotech tool maker Millipore Corp last year to build its lab equipment business.
"We are responding to China's commitment to strengthening regulatory requirements designed to ensure drug safety," said Jean-Paul Mangeolle, head of Merck Millipore's process solutions business.
Merck KGaA, which relies heavily on liquid crystals, the key chemical for TV screens, and on multiple sclerosis and cancer drugs for earnings, acquired American biotech tool maker Millipore Corp last year to build its lab equipment business.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
